Fixed Dose Combination
Showing 51 - 75 of >10,000
Moderate Asthma Trial in São Paulo (Administration of investigation drug, Administration of comparator)
Not yet recruiting
- Moderate Asthma
- Administration of investigation drug
- Administration of comparator
-
São Paulo, BrazilEurofarma Laboratorios S.A
Feb 9, 2023
Healthy Volunteers (Intended Indication: Type 2 Diabetes) Trial in Berlin (Dapagliflozin/sitagliptin FDC, Sitagliptin,
Completed
- Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
- Dapagliflozin/sitagliptin FDC
- +2 more
-
Berlin, GermanyResearch Site
Jun 30, 2022
OSA, Obstructive Sleep Apnea Trial in Los Angeles, Boston, Saint Louis (Period A, Period B, Period C)
Not yet recruiting
- OSA
- Obstructive Sleep Apnea
- Period A
- +2 more
-
Los Angeles, California
- +2 more
Mar 30, 2023
Polycystic Ovary Syndrome (PCOS) Trial in Worldwide (Placebo, Pioglitazone, Spironolactone)
Recruiting
- Polycystic Ovary Syndrome (PCOS)
- Placebo
- +3 more
-
Graz, Austria
- +6 more
Jul 6, 2022
Healthy Subjects Trial in Cheongju-si (DW6014)
Completed
- Healthy Subjects
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
Apr 10, 2023
DW6014 Trial in Cheongju-si (DW6014)
Not yet recruiting
- DW6014
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
Apr 10, 2023
Ezetimibe-Rosuvastatin Evaluation Study
Not yet recruiting
- Hypercholesterolemia
- +2 more
-
Athens, GreeceAthens University Hospital
May 19, 2022
Healthy Subjects Trial in Cheongju-si (SID1903 (FDC), Dapagliflozin and Sitagliptin)
Completed
- Healthy Subjects
- SID1903 (FDC)
- Dapagliflozin and Sitagliptin
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
Oct 24, 2022
Hypertension, Potassium Imbalance Trial in Dhaka (Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg)
Recruiting
- Hypertension
- Potassium Imbalance
- Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg
-
Dhaka, BangladeshNational Heart Foundation of Bangladesh
Jan 21, 2022
Healthy Volunteer Trial in Suzhou (Dapagliflozin/metformin XR FDC 5/500 mg, Dapagliflozin/metformin XR FDC 10/1000 mg,
Completed
- Healthy Volunteer
- Dapagliflozin/metformin XR FDC 5/500 mg
- +3 more
-
Suzhou, ChinaResearch Site
Apr 25, 2022
HIV Trial (DRV/r FDC (120/20mg))
Not yet recruiting
- HIV Infections
- DRV/r FDC (120/20mg)
- (no location specified)
Nov 15, 2023
Third Molar Extraction Trial in São Paulo (FDC of etoricoxib + cyclobenzaprine + etoricoxib , etoricoxib 90 mg (Arcoxia®) +FDC ,
Not yet recruiting
- Third Molar Extraction
- FDC of etoricoxib + cyclobenzaprine + etoricoxib placebo
- +2 more
-
São Paulo, SP, BrazilEurofarma Laboratorios S.A
Jan 11, 2023
Acute Pain Trial in Worldwide (nefopam HCl 30mg / paracetamol 500mg X2, Paracetamol 500 Mg Oral Tablet X2, Nefopam HCl 30 MG
Completed
- Acute Pain
- nefopam hydrochloride 30mg / paracetamol 500mg X2
- +2 more
-
Leuven, Belgium
- +18 more
Nov 10, 2022
Learn More About How Acarbose and Metformin Work When Taken
Recruiting
- Type 2 Diabetes Mellitus
- BAY81-9783 (Acarbose/Metformin)
-
Multiple Locations, IndiaMany locations
Aug 10, 2022
Pain Trial in Salt Lake City (Acetaminophen/Naproxen Sodium Fixed Combination, Naproxen Sodium, Acetaminophen)
Not yet recruiting
- Pain
- Acetaminophen/Naproxen Sodium Fixed Combination
- +3 more
-
Salt Lake City, UtahJBR Clinical Research LLC
Feb 27, 2023
Hepatitis C Infection, HIV Infection Trial in Brazil, Puerto Rico, United States (Glecaprevir/Pibrentasvir (G/P), Ribavirin
Recruiting
- Hepatitis C Infection
- HIV Infection
- Glecaprevir/Pibrentasvir (G/P)
- Ribavirin (RBV)
-
San Diego, California
- +15 more
Dec 19, 2022
Healthy Trial in Jeonju (HCP2201, RLD2205, RLD2206)
Not yet recruiting
- Healthy
- HCP2201
- +2 more
-
Jeonju, Jeollabuk-do, Korea, Republic ofChonbuk National University Hospital
Feb 10, 2023
ALS (Amyotrophic Lateral Sclerosis) Trial in Phoenix (Fixed dose combination Ciprofloxacin/Celecoxib)
Completed
- ALS (Amyotrophic Lateral Sclerosis)
- Fixed dose combination Ciprofloxacin/Celecoxib
-
Phoenix, ArizonaBarrow Neurological Institute
Jan 30, 2022
Vahelva Respimat Regulatory Post-marketing Surveillance in
Completed
- Pulmonary Disease, Chronic Obstructive
- Vahelva® Respimat® (Tiotropium + Olodaterol fixed dose combination)
-
One Or Multiple Sites, Korea, Republic ofChonnam National University Hospital
Feb 28, 2022
Healthy Trial in Ciudad de México (Tirfostina/L-Carnitina)
Enrolling by invitation
- Healthy
- Tirfostina/L-Carnitina
-
Ciudad de México, Azcapotzalco, MexicoPharmet, S.A de C.V.
Aug 2, 2022
COPD Trial (Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination (2 inhalations) via pMDI, Salbutamol 100 mcg Inhaler (2
Withdrawn
- Chronic Obstructive Pulmonary Disease
- Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination (2 inhalations) via pMDI
- Salbutamol 100 mcg Inhaler (2 inhalations) + Ipratropium 20 mcg Inhalation Aerosol (2 inhalations) Free Combination via MDI
- (no location specified)
Sep 3, 2021
Healthy Trial in Mexico City (Fixed dose combination Pregabalin 150 mg / Tramadol 50 mg, Pregabalin 150mg, Tramadol 50 mg)
Completed
- Healthy
- Fixed dose combination Pregabalin 150 mg / Tramadol 50 mg
- +2 more
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
May 19, 2022